![](/accounts/bscai/images/print-logo.png)
Member Exclusive 2024 Webinar: Clinical Impact Forum: Sickle Cell Disease & CGT
-
Register
- Member - Free!
- Advanced Practice Professional Member - Free!
- Complimentary Member - Free!
- Industry Community - Free!
- Industry Community Sub Account - Free!
- Laboratory Member - Free!
- Laboratory Technologist Sub Account - Free!
- Laboratory Regular Member Sub Account - Free!
- Laboratory Resident and Fellow Sub Account - Free!
- Regular Member - Free!
- Resident or Fellow Member - Free!
- Student Member - Free!
- Technologist Member - Free!
Presented by the ISCT ESP Mentoring Program
April 11, 2024
Webinar Description:
This webinar is an informed discussion around the current realities and challenges of cell and gene therapies for sickle cell disease with panelists from various roles/viewpoints in the field.
![Speaker image](https://d54cc24744b91ebd163b-89a60c3eeeb042ba743daf2b8447e4dd.ssl.cf2.rackcdn.com/isct_b301437bdb6142bd9bea5326e8c75082.png)
Kevin Bosse, PhD, RAC-US
Director of Research Regulatory Affairs
Nationwide Children's Hospital, United States
Director of the Office of Research Regulatory Affairs at Nationwide Children’s Hospital. As a RAC-certified regulatory professional, he advises the development and regulatory strategy of novel drugs, biologics and devices with extensive focus on cell and gene therapy.
![Speaker image](https://d54cc24744b91ebd163b-89a60c3eeeb042ba743daf2b8447e4dd.ssl.cf2.rackcdn.com/isct_7a826acf7b6592d36347cb586e9e8d63.png)
Ms Victoria Gray
First sickle cell disease patient, who volunteered in 2019 for the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. Mother of four from Forest, Mississippi, she is a sickle cell warrior having received a CRISPR-based therapy for SCD.
![Speaker image](https://d54cc24744b91ebd163b-89a60c3eeeb042ba743daf2b8447e4dd.ssl.cf2.rackcdn.com/isct_b9a7f3cff9b2652428c42687956ca350.png)
Ms Michele Salter
Chair of the Sickle Cell Society (UK). Michele was formerly the Vice-Chair & Treasurer and has been working for the Sickle Cell Society since 2014, contributing to its goal to support and represent people affected by sickle cell, to improve their overall quality of life.
![Speaker image](https://d54cc24744b91ebd163b-89a60c3eeeb042ba743daf2b8447e4dd.ssl.cf2.rackcdn.com/isct_f94082fff1c79ecab21dd546c16c276f.png)
Akshay Sharma, MD
Clinician-Scientist
Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital
Clinician-scientist in the Department of Bone Marrow Transplantation and Cellular Therapy at St. Jude Children’s Research Hospital. He is an expert in development of novel gene editing therapeutics, and his research includes transplant and gene therapy clinical trials for patients with SCD.
Key:
![](/images/product-status-icons/complete-small.png)
![](/images/product-status-icons/next-small.png)
![](/images/product-status-icons/disabled-small.png)
![](/images/product-status-icons/optional-small.png)
![](/images/product-status-icons/locked-small.png)